[Leukotoxic effect of homologous human antileukocyte plasma (HALP)].
D000293:Adolescent; D000328:Adult; D005260:Female; D005334:Fever / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D007518:Isoantibodies / Q000032:analysis; D007938:Leukemia / Q000097:blood; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology*; D007964:Leukocytosis / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010949:Plasma; D014839:Vomiting / Q000139:chemically induced
D007106:Immune Sera; D007518:Isoantibodies
Die leukotoxische Wirkung eines homologen, menschlichen Antileukocytenplasmas (HALP)